Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure

PURPOSE: Investigating the risk of vascular access failure is critical for maintenance hemodialysis (MHD) patients. Erythropoietin stimulating agents (ESA) typically used for anemia of chronic kidney disease (CKD) may also stimulate neointimal hyperplasia, which is the most important factor in late...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Yonsei Med J
Main Authors: Jeong, Hye Yun, Ko, Eun-Jung, Kim, Sang Hoon, Lee, Mi Jung, Cho, Hye Jeong, Yang, Dong Ho, Lee, So-Young
Formato: Artigo
Idioma:Inglês
Publicado: Yonsei University College of Medicine 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5447111/
https://ncbi.nlm.nih.gov/pubmed/28540993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.4.793
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares